Terms: = Head and neck cancer AND CYLD, CYLD1, 1540, ENSG00000083799, USPL2, KIAA0849, CYLDI, CDMT, HSPC057, FLJ31664, FLJ20180, EAC
1455 results:
1. Premature mortality for patients after completely resected early adenocarcinoma of the esophagus or stomach.
Bollschweiler E; Hölscher AH; Markar SR; Alakus H; Drebber U; Mönig SP; Plum PS
Cancer Med; 2024 May; 13(10):e7223. PubMed ID: 38778711
[TBL] [Abstract] [Full Text] [Related]
2. AGA Clinical Practice Guideline on Endoscopic Eradication Therapy of Barrett's Esophagus and Related Neoplasia.
Rubenstein JH; Sawas T; Wani S; Eluri S; Singh S; Chandar AK; Perumpail RB; Inadomi JM; Thrift AP; Piscoya A; Sultan S; Singh S; Katzka D; Davitkov P
Gastroenterology; 2024 Jun; 166(6):1020-1055. PubMed ID: 38763697
[TBL] [Abstract] [Full Text] [Related]
3. Clinico-pathological study of esophageal mucoepidermoid carcinoma: a 10-year survival from a single center.
Wang Y; Wu Y; Zheng C; Li Q; Jiao W; Wang J; Xiao L; Pang Q; Zhang W; Wang J
BMC Gastroenterol; 2024 May; 24(1):156. PubMed ID: 38720257
[TBL] [Abstract] [Full Text] [Related]
4. Phenotypic immune characterization of gastric and esophageal adenocarcinomas reveals profound immune suppression in esophageal tumor locations.
Groen-van Schooten TS; Harrasser M; Seidel J; Bos EN; Fleitas T; van Mourik M; Pouw RE; Goedegebuure RSA; Doeve BH; Sanders J; Bos J; van Berge Henegouwen MI; Thijssen VLJL; van Grieken NCT; van Laarhoven HWM; de Gruijl TD; Derks S
Front Immunol; 2024; 15():1372272. PubMed ID: 38638445
[TBL] [Abstract] [Full Text] [Related]
5. Somatic mutations of esophageal adenocarcinoma: a comparison between Black and White patients.
Lim H; Gingras MC; Zhao J; Byun J; Castro PD; Tsavachidis S; Hu J; Doddapaneni H; Han Y; Muzny DM; Gibbs RA; Amos CI; Thrift AP
Sci Rep; 2024 Apr; 14(1):8988. PubMed ID: 38637560
[TBL] [Abstract] [Full Text] [Related]
6. Targeting SMAD3 Improves Response to Oxaliplatin in Esophageal Adenocarcinoma Models by Impeding DNA Repair.
Ballout F; Lu H; Bhat N; Chen L; Peng D; Chen Z; Chen S; Sun X; Giordano S; Corso S; Zaika A; McDonald O; Livingstone AS; El-Rifai W
Clin Cancer Res; 2024 May; 30(10):2193-2205. PubMed ID: 38592373
[TBL] [Abstract] [Full Text] [Related]
7. Treatment of esophageal adenocarcinoma in patients with a history of bariatric surgery.
Nobel T; Sewell M; Boerner T; Bains MS; Bott MJ; Gerdes H; Gray K; Nishimura M; Park BJ; Shah P; Sihag S; Jones DR; Molena D
J Gastrointest Surg; 2024 Apr; 28(4):337-342. PubMed ID: 38583881
[TBL] [Abstract] [Full Text] [Related]
8. Investigating the causal role of the gut microbiota in esophageal cancer and its subtypes: a two-sample Mendelian randomization study.
Li J; Gao X; Sun X; Li H; Wei J; Lv L; Zhu L
BMC Cancer; 2024 Apr; 24(1):416. PubMed ID: 38575885
[TBL] [Abstract] [Full Text] [Related]
9. Risk of Esophageal Adenocarcinoma After Bariatric Surgery: A Meta-Analysis of Retrospective Studies.
Zhu C; Liu W; Hu D; Peng L
Obes Surg; 2024 May; 34(5):1726-1736. PubMed ID: 38536625
[TBL] [Abstract] [Full Text] [Related]
10. Management of high risk T1 esophageal adenocarcinoma following endoscopic resection.
Leclercq P; Bisschops R; Bergman JJGHM; Pouw RE
Best Pract Res Clin Gastroenterol; 2024 Feb; 68():101882. PubMed ID: 38522880
[TBL] [Abstract] [Full Text] [Related]
11. Esophageal adenocarcinoma heterogeneity in clinicopathology and prognosis: A single center longitudinal study of 146 cases over a 20-year period.
Huang Q; Lew E; Cheng Y; Shinagare S; Deshpande V; Gold JS; Wiener D; Weber HC
Ann Diagn Pathol; 2024 Jun; 70():152285. PubMed ID: 38518703
[TBL] [Abstract] [Full Text] [Related]
12. Comparison of mutation landscapes of pretreatment versus recurrent squamous cell carcinoma of the oral cavity: The possible mechanism of resistance to standard treatment.
Payungwong T; Angkulkrerkkrai K; Chaiboonchoe A; Lausoontornsiri W; Jirawatnotai S; Chindavijak S
Cancer Rep (Hoboken); 2024 Mar; 7(3):e2004. PubMed ID: 38477073
[TBL] [Abstract] [Full Text] [Related]
13. Metformin in Esophageal Carcinoma: Exploring Molecular Mechanisms and Therapeutic Insights.
Papadakos SP; Argyrou A; Lekakis V; Arvanitakis K; Kalisperati P; Stergiou IE; Konstantinidis I; Schizas D; Koufakis T; Germanidis G; Theocharis S
Int J Mol Sci; 2024 Mar; 25(5):. PubMed ID: 38474224
[TBL] [Abstract] [Full Text] [Related]
14. Multi-Omics Analysis Reveals the IFI6 Gene as a Prognostic Indicator and Therapeutic Target in Esophageal cancer.
Viet-Nhi NK; Minh Quan T; Cong Truc V; Anh Bich T; Hoang Nam P; Le NQK; Chen PY; Hung SH
Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38473938
[TBL] [Abstract] [Full Text] [Related]
15. Calcifications in the descending thoracic aorta predict postoperative anastomotic leakages after esophagectomy for cancer.
Tiainen E; Wirta EV; Tyrväinen T; Kuorilehto T; Toikkanen V; Laukkarinen J; Ukkonen M
World J Surg; 2024 May; 48(5):1209-1218. PubMed ID: 38470437
[TBL] [Abstract] [Full Text] [Related]
16. Incidence and Prediction of Unrelated Mortality After Successful Endoscopic Eradication Therapy for Barrett's Neoplasia.
van Munster SN; Verheij EPD; Ozdemir Ö; Toes-Zoutendijk E; Lansdorp-Vogelaar I; Nieuwenhuis EA; Cotton CC; Weusten BLAM; Alvarez Herrero L; Alkhalaf A; Schenk BE; Schoon EJ; Curvers WL; Koch AD; de Jonge PF; Tang TJ; Nagengast WB; Westerhof J; Houben MHMG; Shaheen NJ; Bergman JJGHM; Pouw RE
Gastroenterology; 2024 Jun; 166(6):1058-1068. PubMed ID: 38447738
[TBL] [Abstract] [Full Text] [Related]
17. PARP1-targeted fluorescence molecular endoscopy as novel tool for early detection of esophageal dysplasia and adenocarcinoma.
Marcazzan S; Braz Carvalho MJ; Nguyen NT; Strangmann J; Slotta-Huspenina J; Tenditnaya A; Tschurtschenthaler M; Rieder J; Proaño-Vasco A; Ntziachristos V; Steiger K; Gorpas D; Quante M; Kossatz S
J Exp Clin Cancer Res; 2024 Feb; 43(1):53. PubMed ID: 38383387
[TBL] [Abstract] [Full Text] [Related]
18. Epigenomic analyses identify FOXM1 as a key regulator of anti-tumor immune response in esophageal adenocarcinoma.
Ziman B; Yang Q; Zheng Y; Sheth M; Nam C; Zhao H; Zhang L; Hu B; Bhowmick NA; Sinha UK; Lin DC
Cell Death Dis; 2024 Feb; 15(2):152. PubMed ID: 38373993
[TBL] [Abstract] [Full Text] [Related]
19. Clinicopathological, metastatic and prognostic features of stage IV esophageal adenocarcinoma versus squamous cell carcinoma: a SEER database analysis.
Pan L; Zhang Y; Gao Y; Qiu J
Chin Clin Oncol; 2024 Feb; 13(1):2. PubMed ID: 38372056
[TBL] [Abstract] [Full Text] [Related]
20. Occupational asbestos exposure and risk of esophageal cancer: A systematic review and meta-analysis.
Seyyedsalehi MS; Boffetta P
Int J Cancer; 2024 Jun; 154(11):1920-1929. PubMed ID: 38339891
[TBL] [Abstract] [Full Text] [Related]
[Next]
